Bivalirudin vs. heparin on a background of ticagrelor and aspirin in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A multicenter prospective cohort study

OBJECTIVE: Current guidelines recommend potent P2Y12 inhibitors such as ticagrelor over clopidogrel as part of the dual antiplatelet therapy (DAPT) after ST-segment elevation myocardial infarction (STEMI), irrespective of final management strategy. The aim of this multicenter prospective cohort stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Xiao-Fan, Chen, Hong-Wu, Xu, Jie, Xu, Qi-Zhi, Zhang, Xiao-Hong, Li, Bin-Bin, Xu, Bang-Long, Ma, Li-Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649932/
https://www.ncbi.nlm.nih.gov/pubmed/36386368
http://dx.doi.org/10.3389/fcvm.2022.932054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649932/
https://www.ncbi.nlm.nih.gov/pubmed/36386368
http://dx.doi.org/10.3389/fcvm.2022.932054

Ejemplares similares